PTC Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 05/09/2025 | 8.61 M | $438.63 M | -6.23% | 11.02% |
| BLACKROCK, INC. | 05/02/2025 | 7.77 M | $395.87 M | -1.65% | 9.94% |
| RTW INVESTMENTS, LP | 05/15/2025 | 7.48 M | $381.34 M | 1.22% | 9.58% |
| ARMISTICE CAPITAL, LLC | 05/15/2025 | 5.43 M | $276.96 M | -14.79% | 6.96% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 5.42 M | $276.16 M | 13.20% | 6.94% |
| JANUS HENDERSON GROUP PLC | 05/15/2025 | 2.92 M | $158.15 M | 25.40% | 3.73% |
| TORONTO DOMINION BANK | 05/15/2025 | 2.61 M | $133.17 M | -20.49% | 3.35% |
| STATE STREET CORP | 05/15/2025 | 2.45 M | $125.10 M | -9.35% | 3.14% |
| FMR LLC | 05/12/2025 | 2.01 M | $102.61 M | 145.54% | 2.58% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.87 M | $95.51 M | 4.28% | 2.40% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.51 M | $77.08 M | 45.30% | 1.94% |
| CAMBER CAPITAL MANAGEMENT LP | 05/15/2025 | 1.50 M | $76.44 M | -53.13% | 1.92% |
| D. E. SHAW & CO., INC. | 05/15/2025 | 1.45 M | $73.65 M | -6.29% | 1.85% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 1.37 M | $70.00 M | -4.84% | 1.76% |
| FRANKLIN RESOURCES INC | 05/13/2025 | 1.27 M | $64.87 M | -0.41% | 1.63% |
| UBS GROUP AG | 05/13/2025 | 1.27 M | $64.70 M | 18.54% | 1.63% |
| CITADEL ADVISORS LLC | 05/15/2025 | 1.17 M | $59.50 M | 154.93% | 1.49% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 1.04 M | $54.01 M | 41.56% | 1.33% |
| 05/12/2025 | 1.01 M | $51.43 M | 100.00% | 1.29% | |
| TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.00 M | $50.96 M | 42.86% | 1.28% |
| MORGAN STANLEY | 05/15/2025 | 949.43 K | $48.38 M | -11.58% | 1.22% |
| NORTHERN TRUST CORP | 05/13/2025 | 744.01 K | $37.91 M | 2.20% | 0.95% |
| MARSHALL WACE, LLP | 05/15/2025 | 741.00 K | $37.76 M | 100.00% | 0.95% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 670.20 K | $34.15 M | 2.62% | 0.86% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 662.07 K | $33.74 M | -3.45% | 0.85% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2025 | 628.66 K | $32.04 M | 7.59% | 0.80% |
| JPMORGAN CHASE & CO | 05/12/2025 | 603.48 K | $30.75 M | -7.05% | 0.77% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 602.67 K | $30.71 M | -21.18% | 0.77% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 595.00 K | $30.32 M | 93.97% | 0.76% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2025 | 579.34 K | $29.52 M | 100.00% | 0.74% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 561.84 K | $28.64 M | 434.83% | 0.72% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 516.13 K | $26.30 M | 101.19% | 0.66% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 468.55 K | $23.88 M | -7.98% | 0.60% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 460.43 K | $23.46 M | -18.99% | 0.59% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 05/14/2025 | 455.33 K | $23.20 M | -7.53% | 0.58% |
| BIOIMPACT CAPITAL LLC | 05/15/2025 | 439.98 K | $22.42 M | 1.20% | 0.56% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 413.02 K | $21.05 M | 162.49% | 0.53% |
| PALO ALTO INVESTORS LP | 05/15/2025 | 404.20 K | $20.60 M | 4.60% | 0.52% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 341.72 K | $17.41 M | 262.08% | 0.44% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 337.96 K | $17.22 M | -23.13% | 0.43% |
| PANAGORA ASSET MANAGEMENT INC | 05/15/2025 | 311.78 K | $15.89 M | -0.08% | 0.40% |
| INVESCO LTD. | 05/12/2025 | 310.33 K | $15.81 M | 178.59% | 0.40% |
| CITIGROUP INC | 05/12/2025 | 305.82 K | $15.58 M | 208.40% | 0.39% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 296.57 K | $15.11 M | 28.87% | 0.38% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2025 | 280.31 K | $14.28 M | 58.04% | 0.36% |
| ENSIGN PEAK ADVISORS, INC | 05/14/2025 | 274.27 K | $13.98 M | 31.67% | 0.35% |
| MAN GROUP PLC | 05/15/2025 | 260.86 K | $13.29 M | 100.00% | 0.33% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 224.84 K | $11.46 M | -27.34% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 216.44 K | $11.03 M | -0.20% | 0.28% |
| TREXQUANT INVESTMENT LP | 05/14/2025 | 193.80 K | $9.88 M | -38.17% | 0.25% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
PTC Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 346 institutional investors and hedge funds held shares of PTC Therapeutics, Inc.. The most heavily invested institutionals were:
Global Financial Private Client, LLC: 0
MASSMUTUAL TRUST CO FSB/ADV: 0
VANGUARD GROUP INC: 8.61 M
BlackRock, Inc.: 7.77 M
RTW INVESTMENTS, LP: 7.48 M
ARMISTICE CAPITAL, LLC: 5.43 M
100.82% of PTC Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 96.04 M shares in the last 24 months. This purchase volume represents approximately $4.67 B in transactions.